KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

ZOCOR 40 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

40 MG

 

GENERIC NAME:

SIMVASTATIN

 

MANUFACTURER:

MERCK SHARP & DOHME INTERNATIONAL

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

X

 

INDICATIONS:

Coronary heart disease, prevention

Hypercholesterolemia

Hyperlipidemia

Hypertriglyceridemia

Myocardial infarction, prophylaxis

Stroke, prophylaxis

 

SIDE EFFECTS:

abdominal pain

alopecia

asthenia

cholestasis

cirrhosis

constipation

diarrhea

drowsiness

dyspepsia

elevated hepatic enzymes

fatigue

flatulence

headache

hepatic failure

hepatic necrosis

hepatitis

infection

insomnia

muscle cramps

musculoskeletal pain

myalgia

myasthenia

myoglobinuria

myopathy

nausea/vomiting

pancreatitis

rash (unspecified)

renal tubular obstruction

rhabdomyolysis

weakness

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

alcoholism

children

elderly

electrolyte imbalance

endocrine disease

females

hypotension

infection

myopathy

organ transplant

renal disease

renal failure

renal impairment

seizure disorder

surgery

 

ADULT DOSE:

Antihyperlipidemic-Initial: Oral, 5 to 10 mg once a day in the evening, the dosage being adjusted at four-week intervals. Maintenance: 5 to 40 mg once a day in the evening. Note: For patients taking concurrent immunosuppressive medications, it is recommended that simvastatin therapy begin with 5 mg per day and not exceed 10 mg per day.

 

MAXIMUM ADULT DOSE:

40 mg per day.

 

PEDIATRIC DOSE:

Safety and efficacy have not been established.  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT